📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19. (2023)

First Author: Siggins MK

Attributed to: ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.13585

PubMed Identifier: 36175370

Publication URI: http://europepmc.org/abstract/MED/36175370

Type: Journal Article/Review

Volume: 168

Parent Publication: Immunology

Issue: 3

ISSN: 0019-2805